Large-scale clinical studies in the Chinese population have shown that PPARD rs2016520 polymorphism (also named + 294 T > C or − 87 T > C) is associated with blood glucose, insulin level and insulin resistance, and is a key factor affecting the development of metabolic syndrome and T2DM [12, 13]. The gene discussed is PPARD; the disease is Insulin resistance.